← Back to Screener
Synergy CHC Corp. Common Stock (SNYR)
Price$0.26
Value ScoreA
Growth ScoreC
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-103.15%
Price vs S&P 500 (4W)-20.91%
VGM Score49.46
Market Capitalization$4.01M
P/E Ratio (Annual)3.41x
All Metrics
Book Value / Share (Quarterly)$0.07
P/TBV (Annual)15.86x
Indicated Dividend (Annual)$0.00
Revenue Growth (3Y)-8.93%
Cash Flow / Share (Quarterly)$-0.23
Price vs S&P 500 (YTD)-96.47%
Gross Margin (TTM)65.37%
Net Profit Margin (TTM)-56.98%
EPS (TTM)$-1.36
10-Day Avg Trading Volume12.55M
EPS Excl Extra (TTM)$-1.36
Revenue Growth (5Y)-2.12%
EPS (Annual)$-1.27
ROI (Annual)-53.28%
Gross Margin (Annual)66.83%
Net Profit Margin (5Y Avg)-9.51%
Cash / Share (Quarterly)$0.23
P/E Basic Excl Extra (TTM)2.81x
Revenue Growth QoQ (YoY)-32.77%
EPS Growth (5Y)118.44%
P/E Normalized (Annual)3.41x
ROA (Last FY)-121.42%
Revenue Growth TTM (YoY)8.35%
EBITD / Share (TTM)$-0.83
ROE (5Y Avg)-100.02%
Operating Margin (TTM)-31.83%
Cash Flow / Share (Annual)$-0.23
P/B Ratio0.68x
P/B Ratio (Quarterly)2.88x
Net Income / Employee (Annual)$-440,800
EV / Revenue (TTM)0.93x
Net Interest Coverage (TTM)-1.06x
ROA (TTM)-74.53%
EPS Growth QoQ (YoY)-88.04%
EV / EBITDA (TTM)3.32x
EPS Incl Extra (Annual)$-1.27
Current Ratio (Annual)1.22x
Quick Ratio (Quarterly)0.73x
3-Month Avg Trading Volume2.46M
52-Week Price Return-85.14%
EV / Free Cash Flow (Annual)5.35x
P/E Incl Extra (TTM)2.81x
Revenue / Employee (TTM)$989,400
Tangible BV / Share (Quarterly)$0.04
P/S Ratio (Annual)0.13x
Asset Turnover (Annual)2.99x
52-Week High$4.00
Operating Margin (5Y Avg)0.32%
EPS Excl Extra (Annual)$-1.27
26-Week Price Return-87.22%
Quick Ratio (Annual)0.73x
13-Week Price Return-79.31%
Total Debt / Equity (Annual)1.91x
Current Ratio (Quarterly)1.22x
Enterprise Value$28.20M
Revenue / Share Growth (5Y)-6.95%
Asset Turnover (TTM)1.83x
Revenue / Employee (Annual)$1,085,000
Inventory Turnover (Annual)3.70x
Pretax Margin (Annual)-40.24%
Cash / Share (Annual)$0.23
3-Month Return Std Dev100.57%
Gross Margin (5Y Avg)68.46%
Net Income / Employee (TTM)$-563,800
EBITDA CAGR (5Y)12.82%
EBITDA Interim CAGR (5Y)-4.00%
ROE (Last FY)-155.15%
Net Interest Coverage (Annual)-1.29x
EPS Basic Excl Extra (Annual)$-1.27
P/FCF (TTM)6.42x
Receivables Turnover (TTM)4.71x
EV / Free Cash Flow (TTM)3.37x
Total Debt / Equity (Quarterly)1.04x
EPS Incl Extra (TTM)$-1.36
Receivables Turnover (Annual)4.71x
ROI (TTM)-31.03%
P/S Ratio (TTM)0.14x
Pretax Margin (5Y Avg)-9.18%
Revenue / Share (Annual)$3.12
Tangible BV / Share (Annual)$0.13
Forward P/E0.83x
Price vs S&P 500 (52W)-113.34%
P/E Ratio (TTM)2.81x
EPS Growth TTM (YoY)-39.32%
Year-to-Date Return-85.54%
5-Day Price Return5.49%
EPS Normalized (Annual)$-1.27
ROA (5Y Avg)-44.56%
Net Profit Margin (Annual)-40.62%
Month-to-Date Return-13.67%
Cash Flow / Share (TTM)$0.02
EBITD / Share (Annual)$-0.63
Operating Margin (Annual)-20.75%
LT Debt / Equity (Annual)1.42x
ROI (5Y Avg)-61.34%
P/E Excl Extra (TTM)2.81x
LT Debt / Equity (Quarterly)0.04x
EPS Basic Excl Extra (TTM)$-1.36
P/TBV (Quarterly)4.58x
P/B Ratio (Annual)3.85x
Inventory Turnover (TTM)3.70x
Pretax Margin (TTM)-56.57%
Book Value / Share (Annual)$0.53
Price vs S&P 500 (13W)-89.05%
Net Margin Growth (5Y)34.23%
Beta-5.62x
P/FCF (Annual)9.50x
Revenue / Share (TTM)$2.45
ROE (TTM)-71.59%
52-Week Low$0.24
vGradeA
gGradeC
mGradeF
vgmGradeC
Show chart for
Earnings Surprise History
Q1 26-0.23est. 0.04
Analyst Recommendations
Feb 2026
Mar 2026
Apr 2026
May 2026
4.14
4.13
4.13
4.13
Industry Peers — Pharmaceutical Preparations(17)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
SNYRSynergy CHC Corp. Common Stock | A | C | F | $0.26 |
| DFTXDefinium Therapeutics, Inc. Common Shares | — | — | A | $24.06 |
| CRONCronos Group Inc. Common Share | C | B | B | $2.82 |
| TLRYTilray Brands, Inc. Common Stock | B | B | D | $5.49 |
| CGCCanopy Growth Corporation Common Shares | B | D | D | $1.08 |
| USNAUSANA Health Sciences Inc | B | D | D | $18.33 |
| NAGENiagen Bioscience, Inc. Common Stock | C | B | D | $3.61 |
| SNDLSundial Growers Inc. Common Shares | A | C | C | $1.46 |
| ACBAurora Cannabis Inc. Common Shares | B | D | D | $3.64 |
| MDWDMediWound Ltd. | D | F | D | $13.82 |
| FTLFFitLife Brands, Inc. Common Stock | B | C | D | $9.91 |
About
Synergy CHC Corp markets and distributes branded consumer health and wellness products including FOCUSfactor, Flat Tummy Tea, Hand MD, and Neuragen across multiple distribution channels. The company focuses on health-conscious consumers seeking nutrition, weight management, cognitive health, skincare, and wellness solutions. Flat Tummy operates as a dedicated lifestyle brand targeting women's nutrition and weight management needs.